Sign In

Login

Password

Forgot Password ? Sign Up

Malariaimpfstoff (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Malariaimpfstoff" in German language version.

refsWebsite
Global rank German rank
24doi.org
2nd place
3rd place
22nih.gov
4th place
7th place
2who.int
195th place
255th place
2tagesschau.de
884th place
51st place
1cdc.gov
218th place
968th place
1theguardian.com
12th place
25th place
1spiegel.de
66th place
4th place
1aerztezeitung.de
low place
711th place
1aerzteblatt.de
3,043rd place
200th place
1endpts.com
low place
low place
1faz.net
240th place
13th place
1zeit.de
267th place
15th place
1eurekalert.org
3,538th place
1,951st place
1science.org
1,160th place
2,116th place
1ox.ac.uk
613th place
1,083rd place

aerzteblatt.de

aerztezeitung.de

cdc.gov

doi.org

  • Bruno Douradinha, Maria M. Mota, Adrian J. F. Luty, Robert W. Sauerwein: Cross-Species Immunity in Malaria Vaccine Development: Two, Three, or Even Four for the Price of One? In: Infection and Immunity. Band 76, Nr. 3, 1. März 2008, S. 873–878, doi:10.1128/IAI.00431-07, PMID 18056479.
  • Wolfram Gottfried Metzger et al.: Entwicklung von Impfstoffen gegen Malaria – aktueller Stand. In: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. Band 63, Nr. 1, Januar 2020, S. 45–55, doi:10.1007/s00103-019-03070-1, PMID 31828371, PMC 7223738 (freier Volltext).
  • Yannick Borkens: Malaria-Antigene in der Ära der mRNA-Impfstoffe. In: Monatsschrift Kinderheilkunde. Band 170, Nr. 9, 1. September 2022, S. 828–838, doi:10.1007/s00112-022-01554-0, PMID 35855690, PMC 9281189 (freier Volltext).
  • Camilla Rothe et al.: Empfehlungen zur Malariaprophylaxe. In: Flugmedizin - Tropenmedizin - Reisemedizin (FTR). Band 29, Nr. 4. Thieme, 2022, S. 144–182, doi:10.1055/a-1919-2660.
  • P. Graves, H. Gelband: Vaccines for preventing malaria (pre-erythrocytic). In: The Cochrane database of systematic reviews. Nummer 4, 2006, S. CD006198, doi:10.1002/14651858.CD006198, PMID 17054280.
  • L. Foquet, C. C. Hermsen, G. J. van Gemert, E. Van Braeckel, K. E. Weening, R. Sauerwein, P. Meuleman, G. Leroux-Roels: Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. In: The Journal of clinical investigation. Band 124, Nummer 1, Januar 2014, S. 140–144, doi:10.1172/JCI70349, PMID 24292709, PMC 3871238 (freier Volltext).
  • Tinto H. et al. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial In: Lancet. N2015 Jul 4;386(9988), doi:10.1016/S0140-6736(15)60721-8, PMID 25913272.
  • Jules Freund et al.: Immunization of monkeys against malaria by means of killed parasites with adjuvants. In: The American journal of tropical medicine and hygiene. Band 28, Nr. 1, Januar 1948, doi:10.4269/ajtmh.1948.s1-28.1, PMID 18898694 (englisch).
  • Ruth Sonntag Nussenzweig et al.: Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. In: Nature. Band 216, Nr. 5111, 14. Oktober 1967, S. 160–162, doi:10.1038/216160a0, PMID 6057225 (englisch).
  • Karl H. Rieckmann et al.: Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. In: Transactions of the Royal Society of Tropical Medicine and Hygiene. Band 68, Nr. 3, 1974, S. 258–259, doi:10.1016/0035-9203(74)90129-1, PMID 4608063 (englisch).
  • Patricia M. Graves, Hellen Gelband: Vaccines for preventing malaria (SPf66). In: The Cochrane Database of Systematic Reviews. Band 2006, Nr. 2, 19. April 2006, S. CD005966, doi:10.1002/14651858.CD005966, PMID 16625647, PMC 6532709 (freier Volltext) – (englisch).
  • Manuel Elkin Patarroyo et al.: Induction of protective immunity against experimental infection with malaria using synthetic peptides. In: Nature. Band 328, Nr. 6131, 13. August 1987, S. 629–632, doi:10.1038/328629a0, PMID 3302727 (englisch).
  • Agnes Mwakingwe-Omari et al.: Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity. In: Nature. Band 595, Nr. 7866, Juli 2021, S. 289–294, doi:10.1038/s41586-021-03684-z, PMID 34194041 (englisch).
  • Camila Marques-da-Silva et al.: Pre-Erythrocytic Vaccines against Malaria. In: Vaccines. Band 8, Nr. 3, September 2020, S. 400, doi:10.3390/vaccines8030400, PMID 32708179, PMC 7565498 (freier Volltext) – (englisch).
  • Liriye Kurtovic et al.: Recent clinical trials inform the future for malaria vaccines. In: Communications Medicine. Band 1, 2021, S. 26, doi:10.1038/s43856-021-00030-2, PMID 35602185, PMC 9053263 (freier Volltext) – (englisch).
  • Thomas C. Luke, Stephen L. Hoffman: Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. In: The Journal of Experimental Biology. Band 206, Pt 21, November 2003, S. 3803–3808, doi:10.1242/jeb.00644, PMID 14506215 (englisch).
  • Declan Butler: Promising malaria vaccine to be tested in first large field trial. In: Nature. 16. April 2019, doi:10.1038/d41586-019-01232-4 (englisch).
  • J. E. Epstein, K. Tewari, K. E. Lyke, B. K. Sim, P. F. Billingsley, M. B. Laurens, A. Gunasekera, S. Chakravarty, E. R. James, M. Sedegah, A. Richman, S. Velmurugan, S. Reyes, M. Li, K. Tucker, A. Ahumada, A. J. Ruben, T. Li, R. Stafford, A. G. Eappen, C. Tamminga, J. W. Bennett, C. F. Ockenhouse, J. R. Murphy, J. Komisar, N. Thomas, M. Loyevsky, A. Birkett, C. V. Plowe, C. Loucq, R. Edelman, T. L. Richie, R. A. Seder, S. L. Hoffman: Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. In: Science. Band 334, Nummer 6055, Oktober 2011, S. 475–480, doi:10.1126/science.1211548, PMID 21903775.
  • Katharine A. Collins et al.: Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine. In: Scientific Reports. Band 7, 19. April 2017, S. 46621, doi:10.1038/srep46621, PMID 28422178, PMC 5395940 (freier Volltext) – (englisch).
  • Mehreen S. Datoo et al.: Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. In: The Lancet Infectious Diseases. Band 22, Nr. 12, 7. September 2022, S. 1728–1736, doi:10.1016/S1473-3099(22)00442-X, PMID 36087586 (englisch).
  • Kassoum Kayentao et al.: Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria. In: The New England Journal of Medicine. Band 390, Nr. 17, 2. Mai 2024, S. 1549–1559, doi:10.1056/NEJMoa2312775, PMID 38669354 (englisch).
  • J. A. Chan, F. J. Fowkes, J. G. Beeson: Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates. In: Cellular and molecular life sciences : CMLS. Band 71, Nummer 19, Oktober 2014, S. 3633–3657, doi:10.1007/s00018-014-1614-3, PMID 24691798, PMC 4160571 (freier Volltext).
  • V. Lorenz, G. Karanis, P. Karanis: Malaria vaccine development and how external forces shape it: an overview. In: International journal of environmental research and public health. Band 11, Nummer 7, Juli 2014, S. 6791–6807, doi:10.3390/ijerph110706791, PMID 24983392, PMC 4113845 (freier Volltext).
  • W. N. Chia, Y. S. Goh, L. Rénia: Novel approaches to identify protective malaria vaccine candidates. In: Frontiers in microbiology. Band 5, 2014, S. 586, doi:10.3389/fmicb.2014.00586, PMID 25452745, PMC 4233905 (freier Volltext).

endpts.com

eurekalert.org

faz.net

nih.gov

ncbi.nlm.nih.gov

  • Bruno Douradinha, Maria M. Mota, Adrian J. F. Luty, Robert W. Sauerwein: Cross-Species Immunity in Malaria Vaccine Development: Two, Three, or Even Four for the Price of One? In: Infection and Immunity. Band 76, Nr. 3, 1. März 2008, S. 873–878, doi:10.1128/IAI.00431-07, PMID 18056479.
  • Wolfram Gottfried Metzger et al.: Entwicklung von Impfstoffen gegen Malaria – aktueller Stand. In: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. Band 63, Nr. 1, Januar 2020, S. 45–55, doi:10.1007/s00103-019-03070-1, PMID 31828371, PMC 7223738 (freier Volltext).
  • Yannick Borkens: Malaria-Antigene in der Ära der mRNA-Impfstoffe. In: Monatsschrift Kinderheilkunde. Band 170, Nr. 9, 1. September 2022, S. 828–838, doi:10.1007/s00112-022-01554-0, PMID 35855690, PMC 9281189 (freier Volltext).
  • P. Graves, H. Gelband: Vaccines for preventing malaria (pre-erythrocytic). In: The Cochrane database of systematic reviews. Nummer 4, 2006, S. CD006198, doi:10.1002/14651858.CD006198, PMID 17054280.
  • L. Foquet, C. C. Hermsen, G. J. van Gemert, E. Van Braeckel, K. E. Weening, R. Sauerwein, P. Meuleman, G. Leroux-Roels: Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. In: The Journal of clinical investigation. Band 124, Nummer 1, Januar 2014, S. 140–144, doi:10.1172/JCI70349, PMID 24292709, PMC 3871238 (freier Volltext).
  • Tinto H. et al. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial In: Lancet. N2015 Jul 4;386(9988), doi:10.1016/S0140-6736(15)60721-8, PMID 25913272.
  • Jules Freund et al.: Immunization of monkeys against malaria by means of killed parasites with adjuvants. In: The American journal of tropical medicine and hygiene. Band 28, Nr. 1, Januar 1948, doi:10.4269/ajtmh.1948.s1-28.1, PMID 18898694 (englisch).
  • Ruth Sonntag Nussenzweig et al.: Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. In: Nature. Band 216, Nr. 5111, 14. Oktober 1967, S. 160–162, doi:10.1038/216160a0, PMID 6057225 (englisch).
  • Karl H. Rieckmann et al.: Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. In: Transactions of the Royal Society of Tropical Medicine and Hygiene. Band 68, Nr. 3, 1974, S. 258–259, doi:10.1016/0035-9203(74)90129-1, PMID 4608063 (englisch).
  • Patricia M. Graves, Hellen Gelband: Vaccines for preventing malaria (SPf66). In: The Cochrane Database of Systematic Reviews. Band 2006, Nr. 2, 19. April 2006, S. CD005966, doi:10.1002/14651858.CD005966, PMID 16625647, PMC 6532709 (freier Volltext) – (englisch).
  • Manuel Elkin Patarroyo et al.: Induction of protective immunity against experimental infection with malaria using synthetic peptides. In: Nature. Band 328, Nr. 6131, 13. August 1987, S. 629–632, doi:10.1038/328629a0, PMID 3302727 (englisch).
  • Agnes Mwakingwe-Omari et al.: Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity. In: Nature. Band 595, Nr. 7866, Juli 2021, S. 289–294, doi:10.1038/s41586-021-03684-z, PMID 34194041 (englisch).
  • Camila Marques-da-Silva et al.: Pre-Erythrocytic Vaccines against Malaria. In: Vaccines. Band 8, Nr. 3, September 2020, S. 400, doi:10.3390/vaccines8030400, PMID 32708179, PMC 7565498 (freier Volltext) – (englisch).
  • Liriye Kurtovic et al.: Recent clinical trials inform the future for malaria vaccines. In: Communications Medicine. Band 1, 2021, S. 26, doi:10.1038/s43856-021-00030-2, PMID 35602185, PMC 9053263 (freier Volltext) – (englisch).
  • Thomas C. Luke, Stephen L. Hoffman: Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. In: The Journal of Experimental Biology. Band 206, Pt 21, November 2003, S. 3803–3808, doi:10.1242/jeb.00644, PMID 14506215 (englisch).
  • J. E. Epstein, K. Tewari, K. E. Lyke, B. K. Sim, P. F. Billingsley, M. B. Laurens, A. Gunasekera, S. Chakravarty, E. R. James, M. Sedegah, A. Richman, S. Velmurugan, S. Reyes, M. Li, K. Tucker, A. Ahumada, A. J. Ruben, T. Li, R. Stafford, A. G. Eappen, C. Tamminga, J. W. Bennett, C. F. Ockenhouse, J. R. Murphy, J. Komisar, N. Thomas, M. Loyevsky, A. Birkett, C. V. Plowe, C. Loucq, R. Edelman, T. L. Richie, R. A. Seder, S. L. Hoffman: Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. In: Science. Band 334, Nummer 6055, Oktober 2011, S. 475–480, doi:10.1126/science.1211548, PMID 21903775.
  • Katharine A. Collins et al.: Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine. In: Scientific Reports. Band 7, 19. April 2017, S. 46621, doi:10.1038/srep46621, PMID 28422178, PMC 5395940 (freier Volltext) – (englisch).
  • Mehreen S. Datoo et al.: Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. In: The Lancet Infectious Diseases. Band 22, Nr. 12, 7. September 2022, S. 1728–1736, doi:10.1016/S1473-3099(22)00442-X, PMID 36087586 (englisch).
  • Kassoum Kayentao et al.: Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria. In: The New England Journal of Medicine. Band 390, Nr. 17, 2. Mai 2024, S. 1549–1559, doi:10.1056/NEJMoa2312775, PMID 38669354 (englisch).
  • J. A. Chan, F. J. Fowkes, J. G. Beeson: Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates. In: Cellular and molecular life sciences : CMLS. Band 71, Nummer 19, Oktober 2014, S. 3633–3657, doi:10.1007/s00018-014-1614-3, PMID 24691798, PMC 4160571 (freier Volltext).
  • V. Lorenz, G. Karanis, P. Karanis: Malaria vaccine development and how external forces shape it: an overview. In: International journal of environmental research and public health. Band 11, Nummer 7, Juli 2014, S. 6791–6807, doi:10.3390/ijerph110706791, PMID 24983392, PMC 4113845 (freier Volltext).
  • W. N. Chia, Y. S. Goh, L. Rénia: Novel approaches to identify protective malaria vaccine candidates. In: Frontiers in microbiology. Band 5, 2014, S. 586, doi:10.3389/fmicb.2014.00586, PMID 25452745, PMC 4233905 (freier Volltext).

ox.ac.uk

ndm.ox.ac.uk

science.org

spiegel.de

tagesschau.de

theguardian.com

who.int

zeit.de